Patients' perspectives on buprenorphine subcutaneous implant: a case series.

ABSTRACT:

Background

Considering the enormous burden represented by the opioid use disorder (OUD), it is important to always consider, when implementing opioid agonist therapy (OAT), the potential impact on patient's adherence, quality of life, and detoxification. Thus, the purpose of the study is to evaluate how the introduction of a novel OAT approach influences these key factors in the management of OUD.

Case presentation

This article marks the pioneering use of OAT through buprenorphine implant in Europe and delves into the experience of six patients diagnosed with OUD at a relatively young age. The patients, comprising both males and a female, are of Caucasian Italian and African Italian ancestry (case 4) and exhibit an age range from 23 to 63, with an average drug abuse history

SUBMITTER: Pierlorenzi C 

PROVIDER: S-EPMC10998295 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature